These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38631910)
1. Stability of porphyrins and porphyrin precursors in urine and plasma samples: implications for sample handling and storage. Gallagher CJ; Bentley LA; Challenger R; Jones M; Schulenburg-Brand D J Clin Pathol; 2024 Jul; 77(8):574-578. PubMed ID: 38631910 [TBL] [Abstract][Full Text] [Related]
2. Best practice guidelines on first-line laboratory testing for porphyria. Woolf J; Marsden JT; Degg T; Whatley S; Reed P; Brazil N; Stewart MF; Badminton M Ann Clin Biochem; 2017 Mar; 54(2):188-198. PubMed ID: 27555665 [TBL] [Abstract][Full Text] [Related]
3. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience]. Zawirska B; Kwiatkowska W; Nowojska A Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004 [No Abstract] [Full Text] [Related]
4. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)]. Brugsch J; Müller H MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424 [TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. Marsden JT; Rees DC J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454 [TBL] [Abstract][Full Text] [Related]
7. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret. Atchison WD; Peterson RE Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932 [TBL] [Abstract][Full Text] [Related]
8. [Laboratory diagnosis of anomalies of porphyrin metabolism]. Wada O Nihon Rinsho; 1979 Jun; Suppl():1640-3. PubMed ID: 490957 [No Abstract] [Full Text] [Related]
9. [The laboratory diagnostics of disorders of porphyrin metabolism: a lecture]. Klin Lab Diagn; 2012 Oct; (10):33-40. PubMed ID: 23265055 [TBL] [Abstract][Full Text] [Related]
10. Clinical Guide and Update on Porphyrias. Stölzel U; Doss MO; Schuppan D Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196 [TBL] [Abstract][Full Text] [Related]
11. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias. Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628 [TBL] [Abstract][Full Text] [Related]
12. Urinary porphyrins and porphyrin precursors in normal pregnancy. Relationship to urinary total oestrogen excretion, de Klerk M; Weideman A; Malan C; Shanley BC S Afr Med J; 1975 Mar; 49(14):581-3. PubMed ID: 1145381 [TBL] [Abstract][Full Text] [Related]
13. Measurement of urinary porphyrins and porphyrin precursors in Dutch hospital laboratories: a review of quality control over 5 years. Zuijderhoudt FM; Weykamp CW; Willems HL Ann Clin Biochem; 2003 Jul; 40(Pt 4):417-8. PubMed ID: 12880545 [TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of porphyrins is increased in patients with HIV-1 infection. Fuchs D; Artner-Dworzak E; Hausen A; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H AIDS; 1990 Apr; 4(4):341-4. PubMed ID: 2350454 [TBL] [Abstract][Full Text] [Related]
15. A clinical porphyrin unit: four years' experience. Lockwood WH; Poulos V Int J Biochem; 1980; 12(5-6):1085-8. PubMed ID: 7450120 [No Abstract] [Full Text] [Related]
16. Administration of oral activated charcoal in variegate porphyria results in a paradoxical clinical and biochemical deterioration. Hift RJ; Todd G; Meissner PN; Kirsch RE Br J Dermatol; 2003 Dec; 149(6):1266-9. PubMed ID: 14674906 [TBL] [Abstract][Full Text] [Related]
17. ACP Best Practice No 165: front line tests for the investigation of suspected porphyria. Deacon AC; Elder GH J Clin Pathol; 2001 Jul; 54(7):500-7. PubMed ID: 11429419 [TBL] [Abstract][Full Text] [Related]
18. Quantification of Urine and Plasma Porphyrin Precursors Using LC-MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients. Poli A; Manceau H; Nguyen AL; Moulouel B; Dessendier N; Talbi N; Puy H; Junot C; Gouya L; Schmitt C; Lefebvre T Clin Chem; 2023 Oct; 69(10):1186-1196. PubMed ID: 37608428 [TBL] [Abstract][Full Text] [Related]
19. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Sardh E; Rejkjaer L; Andersson DE; Harper P Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984 [TBL] [Abstract][Full Text] [Related]